Z79.622 Abrechenbarer, spezifischer Code Long term (current) use of Janus kinase inhibitor
ICD-10-CM Z79.622 identifies “Long term (current) use of Janus kinase inhibitor” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 21: Factors influencing health status and contact with health services
Von der Angabe „bei Aufnahme vorhanden“ ausgenommen
Hinweise zum Code
Inclusion terms1
Long term (current) use of tofacitinib
Hinweise übergeordneter Ebenen
Kapitel 21 · Factors influencing health status and contact with health services (Z00-Z99)
Note3
- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Z77-Z99 · Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Code also1
any follow-up examination (Z08-Z09)
Z79 · Long term (current) drug therapy
Includes1
long term (current) drug use for prophylactic purposes
Excludes 22
- drug abuse and dependence (F11-F19)
- drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Code also1
any therapeutic drug level monitoring (Z51.81)
Z79.6 · Long term (current) use of immunomodulators and immunosuppressants
Verweise im offiziellen Index
Verweise im offiziellen Index (2)
Long-term(current) (prophylactic) drug therapy (use of) (2)
- Long-term(current) (prophylactic) drug therapy (use of) › Janus kinase inhibitorKrankheitsverzeichnis
- Long-term(current) (prophylactic) drug therapy (use of) › tofacitinibKrankheitsverzeichnis
Offizielle Konversionshistorie
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Frühere Zuordnung: Z79.899
Verlauf
Codeverlauf
Letzte erfasste Änderung · FY2023
Gültig ab
- Hinzugefügt
Long term (current) use of Janus kinase inhibitor
Abrechenbarer Diagnosecode
CDC/NCHS · FY2023Alle Ausgaben (9)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2023 | 2022-10-01 | Hinzugefügt |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Dieser Eintrag ist ein vollständiger Code in der gewählten Ausgabe. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.